Clinical trial
PSMA Response in Metastasized Hormone Sensitive Prostate Cancer - Enzalutamide
NCT05539300
Study timeline
Study start (actual)2023-03-01Date precision: day
Registry last updated2024-01-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
PSMA-PET/CT response evaluationDIAGNOSTIC_TEST
Sponsors & collaborators
UMC Utrechtlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05539300 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.